Template:Nicardipine: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(4 intermediate revisions by the same user not shown)
Line 1: Line 1:


style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Nicardipine|{{fontcolor|#6C7B8B|Nicardipine}}]]'''''
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Nicardipine|{{fontcolor|#6C7B8B|Nicardipine}}]]'''''
|-
|-
Line 33: Line 33:
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE I.V. how supplied storage and handling|How Supplied/Storage and Handling]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE I.V. how supplied storage and handling|How Supplied/Storage and Handling]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE I.V. patient counseling information|Patient Counseling Information]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE I.V. labels and packaging|Labels and Packaging]]
|-
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | CARDENE SR <sup>®</sup> FDA Package Insert
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | CARDENE SR <sup>®</sup> FDA Package Insert
Line 41: Line 41:
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE SR dosage and administration|Dosage and Administration]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE SR dosage and administration|Dosage and Administration]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE SR dosage forms and strengths|Dosage Forms and Strengths]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE SR contraindications|Contraindications]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE SR contraindications|Contraindications]]
Line 61: Line 59:
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE SR nonclinical toxicology|Nonclinical Toxicology]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE SR nonclinical toxicology|Nonclinical Toxicology]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE SR clinical studies|Clinical Studies]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE SR how supplied storage and handling|How Supplied/Storage and Handling]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE SR how supplied storage and handling|How Supplied/Storage and Handling]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE SR patient counseling information|Patient Counseling Information]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE SR labels and packaging|Labels and Packaging]]
|-
|-
|}

Latest revision as of 15:57, 20 February 2014